Multifaceted Effects of Kinase Inhibitors on Pancreatic Cancer Cells Reveals Pivotal Entities with Therapeutic Implications

Pancreatic cancer is one of the most aggressive forms of cancer and is the seventh leading cause of cancer deaths worldwide. Pancreatic ductal adenocarcinoma (PDAC) accounts for over 90% of pancreatic cancers. Most pancreatic cancers are recalcitrant to radiation, chemotherapy, and immunotherapy, hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yoo Na, Patil, Ketki, Ma, Jeonghwa, Dufek, Griffin A., Pai, S. Balakrishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296261/
https://www.ncbi.nlm.nih.gov/pubmed/37371811
http://dx.doi.org/10.3390/biomedicines11061716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296261/
https://www.ncbi.nlm.nih.gov/pubmed/37371811
http://dx.doi.org/10.3390/biomedicines11061716

Ejemplares similares